Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
SGYP
Summary
On Feb. 1, Synergy announced it had met the necessary cash balance requirements to unlock the next tranche of a crucial debt facility.
The announcement follows other positive news: FDA approval of an expanded indication for constipation drug Trulance.
Shares traded down after each announcement; investors remain skeptical Synergy can turn itself around via increasing Trulance prescriptions and cutting cash burn.
While investor pessimism continues to reign, Synergy is in the strongest financial position it has enjoyed in some time.
The worst is likely over, and investors should take notice of that in short order; while the story returns to prescription numbers, the company has bought itself much needed time and flexibility.
https://seekingalpha.com/article/4142547-synergy-clears-another-hurdle-now
Re: Farmas USA
Nada tan dramatico ...
Re: Farmas USA
CELG las grandes empresas, serán altamente beneficiadas por la reforma Fiscal de su curioso presidente ....lo cual hace bajo mi punto de vista , un momento muy favorable para entrar en BigFarmas en mínimos anuales .....el tiempo me dará o quitará la ranzon , pero a parte de CELG (estoy dentro con 200 cromos a +_ 103)ya tengo monitorizada REGN....y midiendo muy mucho la entrada , para afinar lo máximo posible , sin miedo a quedarme fuera, pero intentando estar dentro...😉